secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuphoria Therapeutics Inc. (NEUP)
CIK:        0001191070
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001213900-24-108436
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionomics shareholders approve re-domiciliation to U.S. via Neuphoria; 96% vote in favor
--------------------------------------------------------------------------------

- 96% of votes cast and 87% of shareholders present voted in favor of scheme to re-domicile from Australia to Delaware.
- Supreme Court of New South Wales to consider approval at Dec 16 hearing; conditions include expert opinion unchanged.
- Implementation expected on or about Dec 24, 2024; Neuphoria shares to trade on Nasdaq under symbol 'NEUP'.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024108436/0001213900-24-108436-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1191070/000121390024108436/ea0224532-8k_bionomics.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-108436

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer